CAS 97399-96-7: (2aR,4aS,6aR,10S,12aR,12bS,14bR)-2a,12a-dimethyl-6-oxo-2a,4,4a,6a,7,9,10,11,12,12a,12b,13,14,14b-tetradecahydro-6H-2,3,5-trioxapentaleno[1',6':5,6,7]cyclonona[1,2-a]naphthalen-10-yl 2,6-dideoxy-3-O-methyl-beta-D-arabino-hexopyranoside

Cynatratoside A and Cynanversicoside C are therefore potential candidate drugs for use against Ichthyophthirius multifiliis.

Cynatratoside A is a natural glycoside, which is a type of secondary metabolite isolated from plant sources. Specifically, it is extracted from certain species of the Cynanchum genus, which are known for their bioactive compounds. The mode of action of Cynatratoside A involves the modulation of inflammatory pathways, potentially through the inhibition of pro-inflammatory cytokines and enzymes. This compound has been the subject of scientific investigation due to its promising pharmacological properties. Studies suggest that Cynatratoside A could be useful in developing new therapeutic agents for inflammatory diseases or conditions characterized by oxidative stress. Its applications extend to research in pharmacology and medicinal chemistry, where understanding its effects could lead to innovative treatments. Scientists have shown interest in its potential due to the increasing need for natural products in drug discovery pipelines.